HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Caprock Group LLC

Caprock Group LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 8.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,591 shares of the company’s stock after selling 997 shares during the quarter. Caprock Group LLC’s holdings in HCA Healthcare were worth $4,305,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the stock. Capital World Investors grew its holdings in HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after acquiring an additional 1,019,750 shares during the period. Darsana Capital Partners LP boosted its stake in HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares in the last quarter. TD Asset Management Inc lifted its holdings in shares of HCA Healthcare by 2.7% during the second quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after acquiring an additional 19,812 shares during the period. Epoch Investment Partners Inc. grew its position in HCA Healthcare by 16.4% during the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock worth $203,002,000 after acquiring an additional 88,948 shares during the last quarter. Finally, National Pension Service grew its holdings in HCA Healthcare by 11.9% during the 3rd quarter. National Pension Service now owns 550,654 shares of the company’s stock worth $223,802,000 after acquiring an additional 58,353 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Wells Fargo & Company upped their target price on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 6th. Royal Bank of Canada raised their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. KeyCorp decreased their target price on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a report on Tuesday, October 1st. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $385.00.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 over the last quarter. 1.70% of the stock is owned by company insiders.

HCA Healthcare Price Performance

NYSE:HCA opened at $335.89 on Tuesday. The firm’s 50-day simple moving average is $384.12 and its 200 day simple moving average is $358.11. HCA Healthcare, Inc. has a 52 week low of $245.03 and a 52 week high of $417.14. The firm has a market cap of $85.08 billion, a price-to-earnings ratio of 15.08, a P/E/G ratio of 1.32 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.